Olfactory Neuroblastoma Overview
Learn About Olfactory Neuroblastoma
View Main Condition: Neuroblastoma
- Olfactory neuroblastoma
- Esthesioneuroblastoma
Nebraska Methodist Hospital
Andrew Coughlin is a Plastic Surgeon and an Otolaryngologist in Omaha, Nebraska. Dr. Coughlin and is rated as a Distinguished provider by MediFind in the treatment of Olfactory Neuroblastoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Olfactory Neuroblastoma, Tissue Biopsy, and Gastrostomy. Dr. Coughlin is currently accepting new patients.
Unmc Physicians
Christie Barnes is an Otolaryngologist in Omaha, Nebraska. Dr. Barnes has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Olfactory Neuroblastoma. Her top areas of expertise are Nasal Polyps, Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Gastrostomy. Dr. Barnes is currently accepting new patients.
Nebraska Methodist Hospital
Alireza Mirmiran is a Radiation Oncologist in Omaha, Nebraska. Dr. Mirmiran and is rated as an Advanced provider by MediFind in the treatment of Olfactory Neuroblastoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Small Cell Lung Cancer (SCLC). Dr. Mirmiran is currently accepting new patients.
Background: Olfactory neuroblastoma (ONB) is a rare cancer. It grows from tissue in the upper part of the nose cavity, related to the sense of smell and can affect a person s sense of smell. Researchers want to better understand the health problems of people with ONB. This may help them design better treatment and supportive care studies.
Background: Cancers of the nasal cavity or skull base are rare. They often are not diagnosed until they are at an advanced stage, and they often spread to other parts of the body. These cancers may have mutations in a gene called IDH2. Researchers want to find out if a drug (enasidenib) that targets the IDH2 mutation can help people with these cancers.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center